Ronald Worton

Q: What Schools Are Affiliated With Ronald Worton

Ronald Worton is affiliated with the following schools: Yale University, University of Manitoba, University of Toronto

Ronald Worton's AcademicInfluence.com Rankings

Ronald Worton

Biology

#7654

World Rank

#10607

Historical Rank

Genetics

#742

World Rank

#834

Historical Rank

biology Degrees

Download Badge

Biology

Why Is Ronald Worton Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Ronald G. Worton is a Canadian doctor. Born in Winnipeg, Manitoba, he earned a BSc and MSc from the University of Manitoba and a PhD in medical biophysics from the University of Toronto. Worton pursued post-doctoral studies at Yale University. In 1971, he became director of the diagnostic cytogenetics laboratory at The Hospital for Sick Children in Toronto. Worton became geneticist in chief at the hospital and professor of Medical Genetics at the University of Toronto in 1985. In 1996, he became director of research at the Ottawa General Hospital and chief executive officer of the Ottawa Hospital Research Institute, as well as professor of medicine, University of Ottawa.

(See a Problem?)

Ronald Worton's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

The Duchenne muscular dystrophy gene product is localized in sarcolemma of human skeletal muscle (1988) (638)
Physical separation of hemopoietic stem cells from cells forming colonies in culture (1969) (413)
Cloning of the breakpoint of an X;21 translocation associated with Duchenne muscular dystrophy (1985) (367)
The human dystrophin gene requires 16 hours to be transcribed and is cotranscriptionally spliced (1995) (352)
Myoblast transfer in duchenne muscular dystrophy (1993) (310)
A substitution of cysteine for arginine 614 in the ryanodine receptor is potentially causative of human malignant hyperthermia. (1991) (308)
A cDNA clone from the Duchenne/Becker muscular dystrophy gene (1987) (240)
Dystrophin is expressed in mdx skeletal muscle fibers after normal myoblast implantation. (1989) (233)
Duplicational mutation at the Duchenne muscular dystrophy locus: its frequency, distribution, origin, and phenotypegenotype correlation. (1990) (230)
Muscular Dystrophies—Diseases of the Dystrophin-Glycoprotein Complex (1995) (198)
Dystrophin expression in the human retina is required for normal function as defined by electroretinography (1993) (179)
A physical map of 4 million bp around the Duchenne muscular dystrophy gene on the human X-chromosome (1986) (147)
Molecular and functional analysis of the muscle-specific promoter region of the Duchenne muscular dystrophy gene (1990) (139)
PHYSICAL SEPARATION OF HEMOPOIETIC STEM CELLS DIFFERING IN THEIR CAPACITY FOR SELF-RENEWAL (1969) (138)
A canadian collaborative study of mosaicism in amniotic fluid cell cultures (1984) (134)
Chromosome stability in CHO cells (1977) (134)
Polymorphisms and deduced amino acid substitutions in the coding sequence of the ryanodine receptor (RYR1) gene in individuals with malignant hyperthermia. (1992) (129)
Localization of the mdx mutation within the mouse dystrophin gene. (1988) (128)
Human ribosomal RNA genes: orientation of the tandem array and conservation of the 5' end. (1988) (125)
Duchenne muscular dystrophy involving translocation of the dmd gene next to ribosomal RNA genes. (1984) (119)
Multipoint linkage analysis and heterogeneity testing in 20 X-linked retinitis pigmentosa families. (1990) (111)
Genetics of Duchenne muscular dystrophy. (1988) (111)
Differentiation of Duchenne and Becker muscular dystrophy phenotypes with amino- and carboxy-terminal antisera specific for dystrophin. (1991) (93)
Mechanisms of tandem duplication in the Duchenne muscular dystrophy gene include both homologous and nonhomologous intrachromosomal recombination. (1991) (92)
Partial gene duplication in Duchenne and Becker muscular dystrophies. (1988) (83)
Partial gene duplication as a cause of human disease (1992) (83)
Molecular analysis of a constitutional X-autosome translocation in a female with muscular dystrophy. (1987) (73)
Dystrophin in frameshift deletion patients with Becker muscular dystrophy. (1992) (70)
The role of the skeletal muscle ryanodine receptor gene in malignant hyperthermia. (1992) (69)
Point mutation in the human dystrophin gene: identification through western blot analysis. (1991) (68)
Assignment of the gene for complete X-linked congenital stationary night blindness (CSNB1) to Xp11.3. (1989) (64)
Localization of the gene for X-linked recessive type of retinitis pigmentosa (XLRP) to Xp21 by linkage analysis. (1988) (63)
Modulation of the specificity and activity of a cellular promoter in an adenoviral vector. (1997) (61)
Duchenne muscular dystrophy gene expression in normal and diseased human muscle. (1988) (57)
Expression of an X-linked muscular dystrophy in a female due to translocation involving Xp21 and non-random inactivation of the normal X chromosome (2004) (57)
Stability of the human dystrophin transcript in muscle. (1996) (52)
Dystrophin is localized to the plasma membrane of human skeletal muscle fibers by electron‐microscopic cytochemical study (1990) (52)
Segregation of recessive phenotypes in somatic cell hybrids: role of mitotic recombination, gene inactivation, and chromosome nondisjunction (1981) (50)
Evidence for the inheritance of silver-stained nucleolus organizer regions (1978) (47)
Moderate-level gene amplification in methotrexate-resistant Chinese hamster ovary cells is accompanied by chromosomal translocations at or near the site of the amplified DHFR gene (1984) (47)
Dystrophin is tightly associated with the sarcolemma of mammalian skeletal muscle fibers. (1991) (43)
Molecular heterogeneity of translocations associated with muscular dystrophy (1987) (42)
Prenatal identification of a girl with a t(X;4)(p21;q35) translocation: molecular characterisation, paternal origin, and association with muscular dystrophy. (1990) (39)
Anorectal incontinence in myotonic dystrophy: a myopathic involvement of pelvic floor muscles. (1992) (38)
Dystrophin isoforms Dp71 and Dp427 have distinct roles in myogenic cells (1999) (38)
Evidence obtained by induced mutation frequency analysis for functional hemizygosity at theemt locus in CHO cells (1979) (37)
Identification of a transcriptional enhancer within muscle intron 1 of the human dystrophin gene. (1996) (37)
Microcell-mediated cotransfer of genes specifying methotrexate resistance, emetine sensitivity, and chromate sensitivity with Chinese hamster chromosome 2 (1981) (36)
Linkage analysis of polymorphisms within the DNA fragment XJ cloned from the breakpoint of an X;21 translocation associated with X linked muscular dystrophy. (1986) (36)
Evidence for mutation by unequal sister chromatid exchange in the Duchenne muscular dystrophy gene. (1989) (36)
Marker segregation without chromosome loss at theemt locus in Chinese hamster cell hybrids (1980) (34)
Chromosomal alterations associated with overproduction of asparagine synthetase in albizziin-resistant Chinese hamster ovary cells (1983) (34)
Physical mapping at a potential X-linked retinitis pigmentosa locus (RP3) by pulsed-field gel electrophoresis. (1991) (34)
Dic(21;21) in a Down's syndrome child with an unusual chromosome 9 variant in the mother. (1980) (30)
A comparison of the caffeine halothane muscle contracture test with the molecular genetic diagnosis of malignant hyperthermia. (1991) (30)
A muscle-specific enhancer within intron 1 of the human dystrophin gene is functionally dependent on single MEF-1/E box and MEF-2/AT-rich sequence motifs. (1997) (27)
Karyotypic heterogeneity in CHO cell lines. (1978) (27)
Myogenic regulation of dystrophin gene expression. (1989) (25)
Immunogold labelling of dystrophin in human muscle, using an antibody to the last 17 amino acids of the C-terminus (1991) (25)
Linkage analysis in X-linked ocular albinism. (1991) (25)
Expression of the dystrophin isoform Dp71 in differentiating human fetal myogenic cultures. (1996) (24)
The Mouse Dystrophin Enhancer Is Regulated by MyoD, E-box-binding Factors, and by the Serum Response Factor* (2001) (24)
Molecular deletion analysis in Duchenne muscular dystrophy. (1986) (22)
Chromosome replication patterns in an established cell line (CHO). (1977) (21)
The screening of Duchenne muscular dystrophy patients for submicroscopic deletions. (1986) (20)
Linkage of genetic markersemt andchr in Chinese hamster cells (1980) (20)
Partial trisomy 20 confirmed by gene dosage studies. (1979) (18)
Mapping of the human NMDA receptor subunit (NMDAR1) and the proposed NMDA receptor glutamate-binding subunit (NMDARA1) to chromosomes 9q34.3 and chromosome 8, respectively. (1993) (17)
Mapping of four translocation breakpoints within the Duchenne muscular dystrophy gene. (1989) (17)
Legal Rights and Human Genetic Material. (1997) (16)
The mouse dystrophin muscle promoter/enhancer drives expression of mini-dystrophin in transgenic mdx mice and rescues the dystrophy in these mice. (2006) (15)
Duchenne muscular dystrophy: Gene and gene product; mechanism of mutation in the gene (1992) (15)
Molecular genetics of Duchenne and Becker muscular dystrophy. (1988) (15)
Paternal inheritance of translocation chromosomes in a t(X;21) patient with X linked muscular dystrophy. (1986) (14)
Myoblast transfer in DMD: problems in the interpretation of efficiency. (1992) (14)
Gene inactivation as a mechanism for the expression of recessive phenotypes. (1989) (14)
Linkage of genetic markers emt and chr in Chinese hamster cells. (1980) (14)
Somatic events unmask recessive cancer genes to initiate malignancy (1986) (13)
Linkage analysis of a large Latin-American family with X-linked retinitis pigmentosa and metallic sheen in the heterozygote carrier. (1989) (12)
An RNA polymerase from Drosophila (1973) (11)
Autosomal imbalance with a near-normal phenotype: the small effect of trisomy for the short arm of chromosome 18. (1978) (10)
A grandpaternally derived de novo deletion within Xp21 initially presenting in carrier females diagnosed as Kugelberg-Welander syndrome. (1988) (9)
Lithium fluoride thermoluminescence dosimetry. (1966) (8)
Genomic organization of exons 22 to 25 of the dystrophin gene. (1993) (8)
Differential activation of the hprt gene on the inactive X chromosome in primary and transformed Chinese hamster cells (1989) (8)
Mosaicism in amniotic fluid cell cultures. (1977) (8)
Assignment of the gene (UQCRFS1) for the Rieske iron-sulfur protein subunit of the mitochondrial cytochrome bc1 complex to the 22q13 and 19q12-q13.1 regions of the human genome. (1994) (8)
The mouse dystrophin muscle enhancer-1 imparts skeletal muscle, but not cardiac muscle, expression onto the dystrophin Purkinje promoter in transgenic mice. (2004) (8)
ASHG human genome committee report. The human genome project: implications for human genetics. (1991) (7)
Mouse dystrophin enhancer preferentially targets lacZ expression in skeletal and cardiac muscle (2002) (7)
The problem of Duchenne muscular dystrophy. (1988) (5)
Differentiation ofDuchenneandBeckerMuscular Dystrophy Phenotypes withAmino-andCarboxy-Terminal Antisera Specific forDystrophin (1991) (5)
The use of selection and counterselection in microcell-mediated transfer of dominant genetic markers. (1981) (4)
Activation of the hprt gene on the inactive X chromosome in transformed diploid female Chinese hamster cells. (1989) (4)
Chromosome abnormalities: a major cause of birth defects, stillbirth and spontaneous abortion. (1977) (4)
Molecular analysis of Duchenne and Becker muscular dystrophy (1987) (3)
On discovery, genomes, the Society, and society. (2001) (3)
Dystrophin: the long and short of it. (1994) (3)
Section 2: Chromosome disease (1981) (3)
A report on a family with a (1;2) translocation: cytologic and linkage analysis. (1976) (2)
X;autosome translocations in females with Duchenne or Becker muscular dystrophy (reply) (1986) (2)
A711 A COMPARISON OP THE CAFFEINE HALOTHANE CONTRACTURE TEST WITH MOLECULAR GENETICS DIAGNOSIS OF MALIGNANT HYPERTHERMIA (MH) (1990) (2)
Workshop on collaborative studies in prenatal diagnosis of chromosome disease. (1982) (2)
A report on a family with a (1;2) translocation: cytologic and linkage analysis. (1976) (1)
Genetic and biochemical determinations in the pre-transplant workup and in the post-transplant assessment period. (1990) (1)
Gene duplication in evolution (1992) (1)
Letters to the editor (1992) (1)
Moderate-Level GeneAmplification inMethotrexate-Resistant Chinese Hamster OvaryCells IsAccompanied byChromosomal Translocations AtorNeartheSite oftheAmplified DHFR Gene (1984) (1)
Production of the 2400 kb Duchenne muscular dystrophy (DMD) gene transcript; transcription time and cotranscriptional splicing (1994) (0)
Identification of Transcribed Sequences. (1995) (0)
A (2;8) translocation, 46 chromosomes. Repository identification No. GM-327. (1977) (0)
Mechanism for the Expression of Recessive Phenotypes (2006) (0)
A tribute to Margaret W. Thompson (2015) (0)
Touching the “grail”. (1993) (0)
Analysis of an X-autosome translocation responsible for X-linked muscular dystrophy. (1986) (0)
Linkage of markers emt and chr in Chinese hamster cells. (1980) (0)
The DMD gene promoter: a potential role in gene therapy. (1990) (0)
Subject Index Vol. 16, 1976 (1976) (0)
Karyotyping. (2020) (0)
IV: THE ETIOLOGY OF HEREDITARY POLYCYSTIC DISORDERS: PROGRESS IN CLONING DISEASE GENES (1993) (0)
DNA probes for carrier identification in Duchenne muscular dystrophy. (1989) (0)
The era of genetic medicine. (1993) (0)
Molecular genetic approaches to the study of individual risk in alcoholism. (1991) (0)
Forefronts in Nephrology: The molecular basis of renal cystic disease: IV: The Etiology Of Hereditary Polycystic Disorders: Progress In Cloning Disease Genes: The genome project: Implications for genetic renal medicine (1995) (0)
Diagnosis of malignant hyperthermia. (1990) (0)

This paper list is powered by the following services:

Other Resources About Ronald Worton

en.wikipedia.org

What Schools Are Affiliated With Ronald Worton?

Ronald Worton is affiliated with the following schools: